Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
13 people
OSAKA University Venture Capital
OsakaPre-Seed–Growth$3M – $142M
20 people
JAZZ Venture Partners
San FranciscoSeed–Late Stage$100K – $20M
20 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
35 people
AIF
New YorkSeed–Growth
43 people
redalpine
ZugSeed–Late Stage$108K – $2.2M
26 people
RiverVest Venture Partners
St. LouisPre-Seed–Late Stage$500K – $3M
24 people
IQ Capital
LondonPre-Seed–Growth$1M – $40M
23 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
18 people
SR One Capital Management
Redwood CitySeed–Series B
32 people
Investinor
TrondheimPre-Seed–Late Stage
49 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
41 people
Kurma Partners
ParisPre-Seed–Series B$162K – $10.8M
26 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
Bain Capital Venture
BostonPre-Seed–Late Stage
43 people
Legend Capital
BeijingPre-Seed–Growth$2.9M – $156M
25 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Premier Partners
SeoulSeries B
LG Technology Ventures
Santa ClaraSeed–Growth
20 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
25 people
B4 Capital
Pre-Seed–Late Stage$10M – $50M
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
21 people
Houston Angel Network
HoustonPre-Seed–Growth
16 people
Casdin Capital
New YorkSeed–Series C
39 people
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.




















.jpg)
























































